Turning Point Therapeutics, Inc. Debt to Equity Ratio 2019-2022 | TPTX
Current and historical debt to equity ratio values for Turning Point Therapeutics, Inc. (TPTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Turning Point Therapeutics, Inc. debt/equity for the three months ending June 30, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-06-30 | $0.05B | $0.79B | 0.06 |
| 2022-03-31 | $0.05B | $0.89B | 0.05 |
| 2021-12-31 | $0.05B | $0.95B | 0.05 |
| 2021-09-30 | $0.04B | $1.02B | 0.04 |
| 2021-06-30 | $0.04B | $1.07B | 0.03 |
| 2021-03-31 | $0.03B | $1.10B | 0.02 |
| 2020-12-31 | $0.03B | $1.11B | 0.02 |
| 2020-09-30 | $0.02B | $0.70B | 0.03 |
| 2020-06-30 | $0.02B | $0.71B | 0.02 |
| 2020-03-31 | $0.02B | $0.38B | 0.04 |
| 2019-12-31 | $0.02B | $0.40B | 0.04 |
| 2019-09-30 | $0.02B | $0.42B | 0.04 |
| 2019-06-30 | $0.01B | $0.25B | 0.04 |
| 2019-03-31 | $0.01B | $0.09B | 0.11 |
| 2018-12-31 | $0.01B | $0.10B | 0.06 |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.00B | 0.00 | |
